Browsing Tag
Zaynich
5 posts
Wockhardt wins FDA approval for Zaynich as #WOCKPHARMA nears 52-week high
Wockhardt Limited’s Zaynich FDA approval could reshape its antibiotic pipeline story. Find out what it means for investors and Indian pharma.
Wockhardt delivers strong FY25 EBITDA, but net loss persists amid US restructuring drag
Wockhardt posts a 67% EBITDA jump in FY25, but Q4 PAT remains negative. Find out how novel antibiotics like Zaynich and Miqnaf are shaping investor sentiment.
Wockhardt’s Zaynich achieves record-breaking 96.8% clinical cure rate in cUTI Phase III trial
Wockhardt Limited has announced a major breakthrough in the treatment of complicated urinary tract infections (cUTI) with its…
Wockhardt sees Q2 revenue surge, driven by antibiotic innovation and biosimilar expansion
Wockhardt Limited, a leading pharmaceutical and biotechnology company, released its second-quarter financial results for the fiscal year 2024-25,…
Miracle cure: Wockhardt’s experimental drug defeats deadly superbug in dramatic recovery
Wockhardt Limited announced that its investigational drug Zaynich (Zidebactam/Cefepime) has successfully treated a complex case of bacterial meningitis…